Literature DB >> 25630986

Risk Characteristics of Venous Thromboembolism in Chinese Patients.

Hua Wang1, Jian Ye1, Limin Wang1, Weizhong Jin2.   

Abstract

BACKGROUND AND
OBJECTIVE: There is little report concerning risk characteristics of Chinese patients with venous thromboembolism (VTE). The present study was designed to investigate the risk characteristics in Chinese patients with VTE through a retrospective study.
METHODS: A total of 1048 registry patients with VTE in the recent 10 years were analyzed retrospectively with respect to underlying diseases or predisposing factors.
RESULTS: The incidence of VTE in both male and female has been increasing in the recent 10 years. A total of 885 patients were aged more than 50 years, and the mean age of the patients at diagnosis was 58.8 ± 15.7 years. Main risk factors were a prolonged immobilization and malignant tumors, which were different from Western patients.
CONCLUSIONS: This registry demonstrated the different risk characteristics in Chinese patients compared to Western patients. Our results will be available for establishing the prevention of VTE in China.
© The Author(s) 2015.

Entities:  

Keywords:  deep venous thrombosis; pulmonary embolism; thrombosis

Mesh:

Year:  2015        PMID: 25630986     DOI: 10.1177/1076029615569272

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  4 in total

1.  Incidence of clinically suspected venous thromboembolism in British Indian patients.

Authors:  B M Siddiqui; M S Patel; S Rudge; A Best; J Mangwani
Journal:  Ann R Coll Surg Engl       Date:  2018-04-25       Impact factor: 1.891

Review 2.  Magnitudes of Risk Factors of Venous Thromboembolism and Quality of Anticoagulant Therapy in Ethiopia: A Systematic Review.

Authors:  Bekalu Kebede; Tirsit Ketsela
Journal:  Vasc Health Risk Manag       Date:  2022-04-11

3.  Epidemiology of Cancer-Associated Thrombosis in Asia: A Systematic Review.

Authors:  Lai Heng Lee; Chandramouli Nagarajan; Chuen Wen Tan; Heng Joo Ng
Journal:  Front Cardiovasc Med       Date:  2021-05-21

4.  Cost-effectiveness of rivaroxaban compared with enoxaparin plus warfarin for the treatment of hospitalised acute deep vein thrombosis in China.

Authors:  Li Yang; Jingjing Wu
Journal:  BMJ Open       Date:  2020-07-30       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.